2025-04-25 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Review

**0. Key Figures at a Glance:**

* **Cumulative Return (ISRG):** 120.09%
* **Cumulative Return (VOO):** 82.57%
* **Return Difference:** 37.5% (Relative Difference: 40.9%)
* **Current Price:** $508.13
* **5-Day Moving Average:** $485.17
* **20-Day Moving Average:** $487.88
* **60-Day Moving Average:** $530.47
* **RSI:** 52.92
* **PPO:** 0.68
* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **Expected Return (vs. S&P 500, long-term):** 40.7%


**1. Performance Comparison & Company Overview:**

Intuitive Surgical, Inc. (ISRG) is a leading developer and manufacturer of robotic surgical systems.  Over the period analyzed, ISRG significantly outperformed the S&P 500 (VOO), boasting a cumulative return of 120.09% compared to VOO's 82.57%. This represents a 37.5% difference, placing its performance at the 40.9th percentile relative to its historical volatility against the S&P 500.

The provided Alpha and Beta analysis shows varying performance across different timeframes. While CAGR remains consistently high (mostly above 47%), Alpha values fluctuate, sometimes significantly negative, suggesting performance may not always be consistently attributable to outperformance but market-driven.  Beta is consistently high indicating substantial market sensitivity, though seemingly decreasing in the last couple of years. The market capitalization has steadily increased over the years.


**2. Recent Price Movement:**

The current price of $508.13 shows a recent positive change of $4.14 from the previous close.  However, the price is currently below both its 5-day and 20-day moving averages, and significantly below its 60-day moving average. This suggests a potential short-term price correction after a recent surge.  The substantial price increase reflected in the `Last-market` data might indicate a recent price surge, requiring further investigation into market events to understand this.


**3. Technical Indicators & Expected Return:**

The RSI of 52.92 suggests the stock is neither overbought nor oversold.  A PPO of 0.68 indicates a positive momentum. The recent positive change in relative divergence (+4.0) confirms short-term upward momentum.  The MRI of 0.4053 suggests medium risk. The expected return of 40.7% over the long term (2+ years) against the S&P 500, implies significant potential for outperformance if the current trend continues.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2025-04-23 | $1.95  | $2.25B      |
| 2024-10-18 | $1.59  | $2.04B      |
| 2024-07-19 | $1.48  | $2.01B      |
| 2024-04-19 | $1.54  | $1.89B      |
| 2025-04-23 | $1.54  | $1.89B      |

Note that there's a duplicate entry for 2025-04-23.  Assuming this is an error, the data generally shows a fairly consistent revenue stream. EPS is slightly variable, suggesting potential inconsistencies in profitability.  A more comprehensive analysis would require examining the balance sheet and cash flow statements for a clearer picture.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |

Profit margins are consistently high, indicating strong profitability. Revenue shows some fluctuation but generally remains above $2B.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |

Equity is steadily increasing, reflecting the company's growth. ROE is relatively stable, though it shows some fluctuation.


**6. Overall Conclusion:**

ISRG has demonstrated strong historical outperformance against the S&P 500, with a high cumulative return.  However, the recent price movement suggests potential short-term volatility.  High and relatively stable profit margins and consistent revenue streams indicate financial health. While the long-term outlook remains positive considering the projected return, potential investors should be mindful of the stock's high beta (market sensitivity) and carefully consider the risk associated with investing in a single stock. Further investigation into the recent price surge and a more detailed fundamental analysis (including debt levels and future growth projections) are necessary for a comprehensive investment decision.
